Skip to main content
Clinical Trials/NCT06743737
NCT06743737
Recruiting
Not Applicable

Sensitivity and Specificity Study of Electromedical Device Nexkin DSPT and Manual Measurement of Hives in Allergy Skin Prick Tests

Insel Gruppe AG, University Hospital Bern1 site in 1 country200 target enrollmentNovember 1, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Allergy Skin Prick Test Reading
Sponsor
Insel Gruppe AG, University Hospital Bern
Enrollment
200
Locations
1
Primary Endpoint
Measurement of the histamine (positive control) wheal by healthcare professional
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

Skin prick tests (SPTs), or intraepidermal tests, are the first diagnostic approach for people with a suspected allergy. SPTs are very simple, safe and quick. They are cheap tests and are very useful as a screening test for allergy, especially in diseases like bronchial asthma, rhinoconjunctivitis, food/drug allergy and anaphylaxis. Together with the clinical history, SPTs allow to draw conclusions on allergies based on the sensitization pattern.

Nevertheless, the technique itself has evolved very little and continues to be performed entirely manually. This has a few drawbacks that limit the utility of the tests, in many cases limiting them to a purely qualitative assessment.

In comparison to standard practice (manual measurement), the digital skin test reading device Nexkin DSPT can provide the following benefits for project participants: Automates and digitizes the test reading, provides test results in digital format, reduces variability and subjectivity and greater consistency of diagnosis, reduces manual tasks allowing health professionals providing quantitative instead of qualitative results and avoiding potential human errors and allows a faster workflow, resulting in shorter patient visits.

The aim of this study is to validate the clinical utility of the electromedical skin test reading device Nexkin DSPT regarding its use in allergology clinics for the reading of skin prick allergy tests. The overall purpose of the study is to determine the sensitivity and specificity of skin prick tests (SPT) performed using the current practice of the fully manual SPT procedure and those performed using the Nexkin SPT DSPT (digital) procedure and to compare the sensitivity and specificity of both methods.

Registry
clinicaltrials.gov
Start Date
November 1, 2024
End Date
December 31, 2025
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patients who will undergo skin prick tests with panels of aeroallergens and/or foods.
  • Over 18 years of age. The patient or their representative has given consent to participate in the study.
  • The patient must not have taken an antihistamine in the last 5 days.

Exclusion Criteria

  • Patients who are evaluated by more than 40 prick tests. Patients who have taken an antihistamine within the previous 5 days. Patients who are being treated with antidepressants or other drugs with an antihistamine effect.
  • Patients who suffer severe atopic dermatitis with forearm involvement. Patients with dermographism. Patients who are evaluated by intradermal testing. Pregnant women or women suspected to be pregnant. Vulnerable patients

Outcomes

Primary Outcomes

Measurement of the histamine (positive control) wheal by healthcare professional

Time Frame: At enrollment

Measurement of the NaCl (negative control) wheal by healthcare professional

Time Frame: At enrollment

Measurement of the histamine (positive control) wheal by digital device

Time Frame: At enrollment

Measurement of the NaCl (negative control) wheal by digital device

Time Frame: At enrollment

Secondary Outcomes

  • Measure of the time involved in the complete reading and recording of the results(At enrollment)

Study Sites (1)

Loading locations...

Similar Trials